ALB and ovarian carcinoma: Yu et al. calculated the preoperative albumin-to-fibrinogen ratio in 313 patients with advanced epithelial ovarian cancer, irrespective of histologic subtypes, who were treated with neoadjuvant chemotherapy followed by interval cytoreductive surgery.